Contenuti:
Basic Principles of Antisense Technology
Stanley T. Crooke
Medicinal Chemistry of Antisense Oligonucleotides
P. Dan Cook
Analytical Methods for Antisense Drugs
Janet M. Leeds and Lendell L. Cummins
A Role for Antisense Technology in the Discovery of Highly Specific and Versatile Signal Transduction Inhibitors
Brett P. Monia, Erich Koller, and William A. Gaarde
Methods of Selecting Sites in RNA for Antisense Targeting
Susan M. Freier
Properties of Phosphorothioate Oligonucleotides
Pharmacokinetic Properties in Animals
Richard S. Geary, Rosie Z. Yu, Janet M. Leeds, Michael V. Templin, Tanya A. Watanabe, Scott P. Henry, and Arthur A. Levin
Suborgan Pharmacokinetics
Rosanne M. Crooke and Mark J. Graham
Pharmacokinetic Properties in Humans
Rosie Z. Yu, Steven L. Schoenfeld, Richard S. Geary, Tanya A. Watanabe, and Arthur A. Levin
Toxicity of Antisense Oligonucleotides
Arthur A. Levin, Scott P. Henry, David Monteith, and Michael V. Templin
Clinical Safety of Phosphorothioate Oligodeoxynucleotides
F. Andrew Dorr, Josephine M. Glover, and T. Jesse Kwoh
General Pharmacology of Phosphorothioate Oligodeoxynucleotides
C. Frank Bennett
Properties of Advanced Novel Clinical Classes of Oligonucleotides
Pharmacology of 2´-0-(2-Methoxy)ethyl Modified Antisense Oligonucleotides
Nicholas M. Dean, Madeline Butler, Brett P. Monia, and Muthiah Manoharan
Locked Nucleic Acid
Jesper Wengel
Antisense Properties of Peptide Nucleic Acid (PNA)
Uffe Koppelhus and Peter J. Nielsen
Phosphorodiamidate Morpholino Oligomers
Patrick Iversen
Oligonucleotide Conjugates in Antisense Technology
Muthiah Manoharan
Immune Stimulation by Oligonucleotides
Arthur M. Krieg
Pre-mRNA Splicing as a Target for Antisense Oligonucleotides
Ryszard Kole and Danielle Mercatante
Application of Antisense Oligonucleotides to the Study of CNS Protein Function
Siew Peng Ho
Antisense Approach to Isoform-Specific Blockade of Acetylcholinesterase
Hermona E. Soreq and Shlomo Seidman
Serine/Threonine Protein Phosphates
Richard E. Honkanen
Pharmacological Activities of Antisense Drugs: Inflammatory Diseases
James G. Karras, Kathleen J. Myers, and Brenda F. Baker
Respirable Antisense Oligonucleotides (RASONs)
Jonathan W. Nyce
Combined Antisense Therapy and Chemotherapy in Animal Models
Dan Mercola
Antisense Oligodesoxynucleotide Strategies in Renal and Cardiovascular Disease
Hermann Haller, Christian Maasch, Duska Dragun, Maren Wellner, and Friedrich C. Luft
The Development of Antisense Oligonucleotides as Antivirals
Lisa R. Grillone
Clinical Activities in Patients with Solid Tumors or Lymphoma
Jon T. Holmlund
Nucleic Acid Therapeutics for the Treatment of Human Leukemia
Alan M. Gewirtz
ISIS 2302, an Antisense Inhibitor of Intercellular Adhesion Molecule 1 (ICAM-1)
William R. Shanahan, Jr.
New Routes and Novel Formulations for Delivery of Antisense Oligonucleotides
Gregory E. Hardee, Susan P. Weinbach, and Lloyd G. Tillman
DNA-Binding Molecules
Roland W. Bürli and Heinz E. Moser
Targeted Genome Modification via Triple Helix Formation
Margaret A. Macris and Peter M. Glazer
Intracellular Ribozyme Applications
John J. Rossi
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.